1.   Chiron is asking the U.S. Food and Drug Administration advisory panel to recommend an expanded approval of Proleukin to include patients with cancer known as metastatic melanoma.

2.   MIXED REVIEWS FOR CHIRON DRUGS A Food and Drug Administration panel recommended that a Chiron drug be approved to treat metastatic melanoma, a fatal skin cancer.

3.   The cause of death was metastatic melanoma, said Dr. James C. Harris, a family friend.

4.   The cause was metastatic melanoma, said Stanford University, where he was the Davis-Brack Professor of Behavioral Sciences.

5.   The cause was a metastatic melanoma, family members said.

6.   The FDA expanded the approved uses of Proleukin to include patients with cancer known as metastatic melanoma, a serious, spreading form of skin cancer.

7.   The U.S. Food and Drug Administration advisory panel voted unanimously to recommend an expanded approval of Proleukin to include patients with cancer known as metastatic melanoma.

8.   The U.S. Food and Drug Administration advisory panel voted to recommend an expanded approval of Proleukin to include patients with cancer known as metastatic melanoma.